These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3207536)

  • 1. Myoneural blockers and suxamethonium.
    Eisenkraft JB; Herlich A
    Br J Anaesth; 1988 Nov; 61(5):642. PubMed ID: 3207536
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of post-suxamethonium pain by pretreatment with four non-depolarizing agents.
    Bennetts FE; Khalil KI
    Br J Anaesth; 1981 May; 53(5):531-6. PubMed ID: 6112998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of neuromuscular blocking agents on suxamethonium-induced fasciculations and myalgia.
    O'Sullivan EP; Williams NE; Calvey TN
    Br J Anaesth; 1988 Mar; 60(4):367-71. PubMed ID: 3281700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of competitive myoneural blockade and fentanyl on muscle fasciculation caused by suxamethonium in children.
    Lindgren L; Saarnivaara L
    Br J Anaesth; 1983 Aug; 55(8):747-51. PubMed ID: 6882613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The neuromuscular blocking action of suxamethonium following intravenous and intramuscular administration.
    Schuh FT
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):399-403. PubMed ID: 7141759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of rate of stimulation and of fatigue on the response to neuromuscular blocking agents.
    WISLICKI L
    Br J Pharmacol Chemother; 1958 Jun; 13(2):138-43. PubMed ID: 13536277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atracurium v. suxamethonium in a case of organophosphorous poisoning.
    Baraka A; Cava L; Jaoude CA
    Br J Anaesth; 1984 Jun; 56(6):673. PubMed ID: 6547050
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse effects of neuromuscular blockers and their antagonists.
    Naguib M; Magboul MM
    Middle East J Anaesthesiol; 1998 Jun; 14(5):341-73. PubMed ID: 9785339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged paralysis following suxamethonium and the use of neostigmine.
    James MF; Howe HC
    Br J Anaesth; 1990 Sep; 65(3):430-2. PubMed ID: 2223373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Muscle relaxants in the ICU].
    Schneider G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Train-of-four fade of non depolarizing muscle relaxants: an insight into the mechanism of precurarization.
    Erkola O
    Ann Fr Anesth Reanim; 1988; 7(4):299-304. PubMed ID: 3202338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the non-depolarizing drugs in the prevention of suxamethonium bradycardia.
    Mathias JA; Evans-Prosser CD; Churchill-Davidson HC
    Br J Anaesth; 1970 Jul; 42(7):609-13. PubMed ID: 4247670
    [No Abstract]   [Full Text] [Related]  

  • 13. Rocuronium vs. succinylcholine revisited.
    Strayer RJ
    J Emerg Med; 2010 Sep; 39(3):345-6; author reply 346-7. PubMed ID: 20456897
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of pre-treatment with lysine acetyl salicylate on suxamethonium-induced myalgia.
    Naguib M; Farag H; Magbagbeola JA
    Br J Anaesth; 1987 May; 59(5):606-10. PubMed ID: 3107602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular blockers in surgery and intensive care, Part 2.
    McManus MC
    Am J Health Syst Pharm; 2001 Dec; 58(24):2381-95. PubMed ID: 11794954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of hypothermia and hyperthermia on the action of neuromuscular blocking agents. I. Suxamethonium.
    WISLICKI L
    Arch Int Pharmacodyn Ther; 1960 Jun; 126():68-78. PubMed ID: 13845414
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac effects of atropine and gallamine in patients receiving suxamethonium.
    Viby-Mogensen J; Wisborg K; Sørensen O
    Br J Anaesth; 1980 Nov; 52(11):1137-42. PubMed ID: 7426219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The decision to use succinylcholine for critically ill patients should not be based on duration of time in the intensive care unit alone.
    Bittner EA; Martyn JAJ; Gronert GA
    Anesth Analg; 2013 May; 116(5):1182. PubMed ID: 23606469
    [No Abstract]   [Full Text] [Related]  

  • 19. Increase in intragastric pressure during suxamethonium-induced muscle fasciculations in children: inhibition by alfentanil.
    Lindgren L; Saarnivaara L
    Br J Anaesth; 1988 Feb; 60(2):176-9. PubMed ID: 3125850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of activity and pretreatment in the prevention of suxamethonium myalgias.
    Oxorn DC; Whatley GS; Knox JW; Hooper J
    Br J Anaesth; 1992 Aug; 69(2):200-1. PubMed ID: 1389827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.